Tackling amyloidogenesis in Alzheimer's disease with A2V variants of Amyloid-β.

Sci Rep · 2016 · PMC4750079 · PMID 26864599

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The results of the study showed a trend towards cognitive impairment in the control group and an opposite tendency of mice treated with Aβ1-6 A2V TAT(D), whose cognitive performances were no worse than at the beginning of the treatment with Aβ1-6 A2V TAT(D).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.